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Abstract
In spite of decades-long studies, the mechanism of morphogenesis of plus-stranded RNA viruses belonging to the genus
Enterovirus of Picornaviridae, including poliovirus (PV), is not understood. Numerous attempts to identify an RNA
encapsidation signal have failed. Genetic studies, however, have implicated a role of the non-structural protein 2C
ATPase in
the formation of poliovirus particles. Here we report a novel mechanism in which protein-protein interaction is sufficient to
explain the specificity in PV encapsidation. Making use of a novel ‘‘reporter virus’’, we show that a quasi-infectious chimera
consisting of the capsid precursor of C-cluster coxsackie virus 20 (C-CAV20) and the nonstructural proteins of the closely
related PV translated and replicated its genome with wild type kinetics, whereas encapsidation was blocked. On blind
passages, encapsidation of the chimera was rescued by a single mutation either in capsid protein VP3 of CAV20 or in
2C
ATPase of PV. Whereas each of the single-mutation variants expressed severe proliferation phenotypes, engineering both
mutations into the chimera yielded a virus encapsidating with wild type kinetics. Biochemical analyses provided strong
evidence for a direct interaction between 2C
ATPase and VP3 of PV and CAV20. Chimeras of other C-CAVs (CAV20/CAV21 or
CAV18/CAV20) were blocked in encapsidation (no virus after blind passages) but could be rescued if the capsid and 2C
ATPase
coding regions originated from the same virus. Our novel mechanism explains the specificity of encapsidation without
apparent involvement of an RNA signal by considering that (i) genome replication is known to be stringently linked to
translation, (ii) morphogenesis is known to be stringently linked to genome replication, (iii) newly synthesized 2C
ATPase is an
essential component of the replication complex, and (iv) 2C
ATPase has specific affinity to capsid protein(s). These conditions
lead to morphogenesis at the site where newly synthesized genomes emerge from the replication complex.
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Introduction
Morphogenesis is a crucial step at the end of the virus’ life cycle
that provides newly synthesized genomes with a protective shell to
survive in the extracellular environment yet assures attachment to
and penetration into subsequent host cells. Morphogenesis of viral
genomes must be specific because encapsidation of non-progeny
nucleic acid is wasteful for the virus, for which reason elaborate
mechanisms have evolved to discriminate against nucleic acids
other than its own genome.
Here we describe our studies of the morphogenesis of a group of
single, plus-stranded RNA viruses that belong to the genus Enterovirus
of Picornaviridae, a family of viruses containing a large number of
human and animal pathogens. Poliovirus (PV), the prototype
enterovirus, has been extensively studied for a century and although
much is known about its virion structure, uptake into host cell,
genome structure and macromolecular events of replication, the
mechanism of particle assembly is only poorly understood [1]. The
key requirement of morphogenesis, namely the specific selection of
viral genomes, has also remained obscure. We have discovered a
novel mechanism for enteroviruses in which the specificity of
encapsidation is facilitated by protein-protein interaction. It should
be noted that this mechanism is different from the one used by some
other RNA viruses such as hepatitis B virus and alphaviruses [2,3].
Thespecificityofencapsidationwiththesevirusesisdependentonan
RNA encapsidation signal and RNA/protein interactions.
Enteroviruses synthesize only one protein, the polyprotein, which
is cleaved by two virus-encoded proteinases, 2A
pro and 3C
pro/
3CD
pro,intointermediatesexpressingspecificfunctions(e.g.3CD
pro)
and into mature proteins (Figure 1A). After its release from the
polyprotein by 2A
pro, the precursor of the structural proteins (P1)
interacts with cellular chaperone Hsp90 [4], a requirement for its
subsequent processing by 3CD
pro into capsid proteins VP0, VP3 and
VP1(Fig.1A)[5].Thesecleavageproductswillspontaneouslyforma
5S protomer (VP0, VP3, VP1) that can oligomerize to the 14S
pentamer (VP0, VP3, VP1)5; twelve pentamers, subsequently,
assemble into a 75S empty capsid [(VP0, VP3, VP1)5]12, also called
procapsid [6,7]. It is not known at what stage progeny genomes
interact with the capsid precursors. They may be inserted into the
procapsid or, alternatively, pentamers may condense around RNA
emerging from the replication complex. Either process will yield
provirions {[(VP0, VP3, VP1)5]12RNA} [8,9,10] that mature to
virions when VP0 is cleaved to VP4 and VP2 by a mechanism
possibly involving an RNA-dependent autocatalytic process [6,7].
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restricted to newly synthesized plus strand progeny RNA [11,12].
Under normal conditions of replication in HeLa cells, cellular
RNAs, PV mRNA lacking VPg or viral VPg-linked minus strand
RNA are excluded from mature viral particles [6]. Numerous
studies aimed at determining the specificity of encapsidation by
searching for an RNA packaging signal have been unsuccessful.
The very long 59NTR of PV can be replaced with that of the
distantly related coxsackie B3 virus (CVB3) [13] or CVB4 [14]
yielding virions containing chimeric genomes that proliferate with
PV wild type (wt) kinetics. Similarly, the cloverleaf of PV can be
changed to that of HRV2 [15], or the PV IRES has been
exchanged with IRESes from other picornaviruses [16,17,18] and
even with that of HCV [19] without yielding impaired encapsida-
tion phenotypes. The 39NTR of PV, in turn, has been exchanged
with that of HRV14, a single stem-loop structure with no apparent
similarity in structure and sequence to that of PV. This chimera
too proliferated with wt kinetics [20]. This makes it highly unlikely
that the 59- and 39-NTRs of poliovirus contain packaging
determinants. The genomic sequence encoding the capsid P1
precursor cannot harbor an encapsidation signal since the entire
P1 encoding region can be deleted [21] or replaced by foreign
genes [14,22,23]. Such PV replicons, all of which can replicate,
can be efficiently encapsidated with PV capsid proteins in trans.
Recent experiments from this laboratory, employing a ‘‘scram-
bled’’ sequence [24] of the P2 coding region (scramble of
synonymous codons) have eliminated this region too from carrying
an encapsidation signal (Song, Mueller, Ward, Skiena, Futcher,
Paul and Wimmer, manuscript in preparation). Finally, genetic
modification of the PV VPg coding sequence [25,26] or
engineering PVs carrying VPg sequences of other picornaviruses
[25,27,28] have also eliminated the VPg coding sequence as
providing an encapsidation signal. VPg, however, may still play a
role in encapsidation (see below). Currently it seems unlikely that
poliovirus or other enteroviruses (including the rhinoviruses that
have recently been classified as enteroviruses) harbor an RNA
signal that would instruct the capsid components to bind to and
enclose the viral genome in a specific manner. Only one member
of the extended family of Picornaviridae, Aichi virus (Kobuvirus genus),
was reported to contain a 59-terminal RNA stem loop with a role
in particle assembly [29].
Among the nonstructural proteins of PV, 2C
ATPase and 3CD
pro,
have been reported to be involved in packaging although no
mechanism(s) is known. Studies with an in vitro translation/RNA
replication system, which produces viable viruses [11], have
suggested that 3CD
pro functions at a late step in the assembly
process just beforeorduringthematuration cleavage ofVP0toVP2
and VP4 [30]. Protein 2C
ATPase of PV has been implicated in virion
capsid formation through genetic analysis of a cold-sensitive mutant
[31] or by determining escape mutants from drug (hydantoin)
inhibition [32]. The multifunctional 329 amino acids-long 2C
ATPase
is the most complex and least understood nonstructural proteins of
enteroviruses. The functions of this protein that are highly
conserved among picornaviruses, include, in addition to encapsida-
tion, host cell membrane rearrangements [33,34], genome
replication [35,36] and even uncoating of viral particles [37]. Based
on sequence analyses the protein has been classified as a member of
the superfamily III helicases, which contain 3 conserved motifs (A–
C), including two classical ATP binding motifs (A and B) (Fig. 1B)
[38]. Purified 2C
ATPase possesses ATPase activity [39,40], which is
inhibited by guanidine HCl (GnHCl) [41], a known potent inhibitor
of PV RNA replication [18]. In vitro the protein forms homo-
oligomeric structures required for ATPase activity [42]. The N-
terminal part of the protein contains a RNAbindingdomainand an
amphipathic helix, which is involved in membrane binding and
oligomerization [36,42,43]. Another amphipathic helix, a RNA
binding domain and a cysteine rich domain that binds zinc are
located near the C-terminus [44,45]. In infected cells 2C
ATPase
appears to be associated with viral RNA in the replication
complexes on the surface of membranous vesicles [46].
Available evidence suggests that genome replication is a
precondition of PV encapsidation [11,12]. Electron-microscopic
studies, which showed that RNA replication complexes co-localize
with capsid precursors on membranous vesicles during infection
[47], supported these observations. Nugent et al. [12] hypothe-
sized that encapsidation specificity may be determined by the
spatial arrangement of replication complexes with the capsid
precursors. This intriguing hypothesis lacked an essential compo-
nent: what brings the capsid precursors into the vicinity of the
replication complexes since PV replicons lacking the P1 domain
altogether can be efficiently encapsidated in trans?
Human enteroviruses have been divided into several clusters
based on genotype relationships [48]. PV types 1–3, and eleven C-
cluster coxsackie A virus serotypes share the C-cluster, also
referred to as C-cluster human enteroviruses (C-HEVs). Their
difference in affinity to cellular receptors, PVs using CD155
[49,50] while C-CAVs using ICAM-1 [51], accounts for significant
capsid dissimilarities between the member viruses of this species
[52,53]. In contrast, the differences between the non-structural
proteins of PV vs C-CAVs are less pronounced. We have used the
similarities and dissimilarities between PV and C-CAVs to
separate RNA replication from encapsidation by constructing
chimeric viruses in which capsid precursor P1 and/or 2C
ATPase
have been exchanged. All of the chimeric viruses studied here
replicated their genomes with wt kinetics in tissue culture cells but
were blocked in encapsidation, a phenotype that we examined by
genetic analyses. We present genetic evidence suggesting a specific
interaction between 2C
ATPase and VP3, which is essential for
genome encapsidation. The genetic evidence of the 2C
ATPase-VP3
interaction was further substantiated by biochemical assays. We
Author Summary
Enteroviruses are single, plus-stranded RNA viruses that
contain a large number of closely related pathogens.
Human enteroviruses cause altogether .3 billion human
infections per year, inflicting diseases ranging from benign
(common cold) to very serious (poliomyelitis). Enterovirus
replication has been studied for decades yet the mecha-
nism of genome selection during encapsidation, a key step
open for chemotherapeutic intervention, remains un-
known. Attempts to identify a genomic ‘‘packaging
signal’’, instructing the genome to engage with capsid
proteins in morphogenesis, have failed. We have used the
similarities and dissimilarities of two closely related
subspecies of enteroviruses, poliovirus and coxsackie A
viruses (CAVs), and constructed chimeras in which the
capsid coding region was interchanged. A chimera, with
the CAV capsid domain and the poliovirus two non-
structural domains of the polyprotein, synthesized its
genome with wt kinetics yet was blocked in morphogen-
esis. Genetic and biochemical studies of chimeras led to
the discovery that the non-structural protein 2C
ATPase
(essential part of the replication complex) and capsid
protein VP3 must directly interact for morphogenesis to
proceed. This has led us to propose a novel mechanism by
which the specificity of enterovirus morphogenesis is
governed by protein-protein rather than RNA-protein
interaction at the site of genome synthesis.
Interaction of 2C
ATPase and VP3 in Morphogenesis
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in the enterovirus life cycle is protein-protein interaction.
Materials and Methods
Cells
HeLa H1 cells were maintained in DMEM (Life Technology),
supplemented with 10% FCS, 100 units of penicillin, and 100 mg
of streptomycin per milliliter.
Viruses
The prototype strain of C-CAVs, CAV20, CAV21 (Kuykendall)
and CAV18, propagated in HeLa H1 cells, were obtained from
the American Type Culture Collection. Polioviruses (PVM) were
derived from cDNA pT7PVM [54] by transfection.
Plasmids
Parental plasmids of PV: pT7PVM contain a full-length infectious
cDNA of PVM.
Parental plasmids of C-CAVs: pT7CAV20 contains a full-length
infectious cDNA of CAV20 [48]. pGEM-CAV21 and pT7CAV18,
which contain a full length infectious cDNA of CAV21 and CAV18
(Kuykendall), respectively, were constructed by Elizabeth Rieder.
Chimeric genomes: Parental plasmids of PVs and C-CAVs were
used as the backbone for cloning as described below. All plasmids
contain the T7 promoter in front of the 59 end of the full length
genomic cDNA for in vitro RNA transcription by T7 RNA
polymerase [54].
Construction of chimeric genomes between C-CAVs
Parental plasmid cDNAs of CAV20, CAV21 and CAV18 were
used as the backbone for cloning. Using a three-step overlapping
PCR, chimeras between CAV20 and CAV21 (or CAV18) were
generated by precise swapping of the genetic segment encoding the
P1 region of the polyprotein [48]. The oligonucleotides and the
templates for PCR are summarized in Supplementary Table 2 in
Text S1. The overlapping PCR fragment and the vectors were
digested with the same pair of restriction enzymes and ligated to
produce the cDNA clone of the chimeric genome. The vectors and
the restriction sites for construction of the chimeric genomes are
listed in Supplementary Table 3 in Text S1. The DNA sequence of
the final constructs was verified by sequencing analysis using BigDye
Kit andABIPrism DNAsequencer (model 310).Replacementofthe
original 2C
ATPase coding region ineach of the chimeric genome with
that of the same origin as the capsid coding region follows the same
strategy described above (Supplementary Table 2 & 4 in Text S1).
Figure 1. The genomic organization of C-HEV RNAs, proteolytic processing of the polyprotein and PV 2C
ATPase motifs. (A) The single-
stranded genomic RNA is covalently linked to the viral-encoded protein VPg at the 59 end of the NTR (59NTR). The 59NTR consists of the cloverleaf,
and the IRES. The coding region (open box) depicts the structural (P1) and nonstructural (P2 and P3) regions. Within the P2 (2C
ATPase) coding region,
the cis replication element (cre) is indicated. The 39NTR contains a heteropolymeric region and is polyadenylated. The precursors and mature cleavage
products of the P1, P2 and P3 domains along with their cleavage sites are shown. (B) Functional motifs in 2C
ATPase. Motifs A and B are homologous to
those in NTP binding/hydrolyzing proteins, motif C shares homology to superfamily helicase III. Two RNA binding motifs, two amphipathic helixes,
the N-terminal membrane binding motif, oligomerization motif and the C-terminal zinc-binding motif are indicated. Amino acid positions of each
motif are numbered.
doi:10.1371/journal.ppat.1001066.g001
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Construction of the chimeric C20PP genome was described
before [48]. For construction of the C20PP derivatives, listed in
Supplementary Table 3 in Text S1 and Figure 4, a two-step
overlapping PCR similar to the one described above was
performed using C20PP as the template with the mutation(s)
introduced into the internal primers (Supplementary Table 3 & 4
in Text S1).
Construction of Renilla luciferase reporter viruses
To test the RNA replication efficiency of chimeric viruses, we
used novel reporter viruses, which contain the Renilla luciferase
gene fused to the N-terminal of the P1 coding region of the
chimeric genomes. The same strategy (three-step overlapping
PCR), described above, was used to introduce the Renilla
luciferase gene into the N-terminal of P1 the coding region of
the chimeric genomes (Supplementary Table 3 & 4 in Text S1).
The luciferase protein is post-translationally cleaved from the
remainder of the polyprotein by 3CD
pro at a recombinant 3CD
pro
cleavage site.
Analysis of the growth phenotypes of the parental and
chimeric viruses
Parental plasmid cDNAs pT7PVM, pT7CAV20, pGEM-
CAV21, pT7CAV18 and the chimeric constructs were linearized
at a unique restriction sites downstream the poly(A) tract
(Supplementary Table 5 in Text S1) and used as templates for in
vitro RNA synthesis using T7 RNA polymerase. RNA transcripts
were transfected into HeLa H1 cell monolayers by the DEAE-
Dextran method as described before [54]. Following transfection,
virus was harvested from the transfected cells when 90–95% of the
cells displayed cytopathic effect (CPE). Lysates of transfected cells
from the chimeric genomes showing no CPE were inoculated into
35-mm-diameter HeLa H1 cell monolayers for 6–8 subsequent
serial passages. The plaque phenotypes and virus titers (PFU/ml) of
the parental and chimeric viruses were determined in triplicate by
plaque assay [11] using 0.6% tragacanth gum. The identity of the
chimeric viruses was confirmed by RT-PCR/sequencing analysis.
In vitro translation
In vitro RNA translations were performed with HeLa cell S10
cytoplasmic extracts at 34 degree Celsius as described previously
[11].
RT-PCR and sequencing analysis of viral RNA
HeLa H1 cell monolayers (5610
6) were infected with viruses
that were purified from plaque assay. At 7-hr post infection, total
cytoplasmic RNA was extracted with 1 ml Trizol reagent
(Invitrogen) and amplified into DNA using Titan one tube RT-
PCR system (Roche). The RT-PCR products were sequenced
using the Bigdye Terminator Sequencing Kit (ABI, Applied
Biosystems).
Luciferase assay
Dishes (35-mm diameter) of monolayered HeLa H1 cells were
transfected with 5 mg of replicon RNAs and were incubated at 37
degree Celsius in standard tissue culture medium in the presence
and absence of 2 mM GnHCl. Luciferase activities were
determined in lysates of cells harvested 16 hrs after transfection.
Cell lysates (10 ml) was mixed with 20 ml of luciferase assay reagent
(Promega; luciferase assay system catalog no. E2810) and Renilla
luciferase activity was measured in an Optocomp I luminometer
(MGM Instruments, Inc.). Cell lysates from transfections were
used to re-infect HeLa H1 cells in the presence and absence of
2 mM GnHCl and luciferase activities were determined in lysates
of cells harvested 8 hrs after infection. Luciferase activity ratio
(2GnHCL/+GnHCl) represents: luciferase activity without
GnHCl divided by luciferase activity with GnHCl in either
transfection or infection.
Construction of His-tagged VP3
A PCR fragment containing full length PV VP3 was amplified
and cloned into the pET21b vector (Novagen) with the restriction
enzymes Sac I and Xho I.
Purification of GST-2C
ATPase and His-tagged VP3 proteins
GST-tagged 2C
ATPase and His-tagged VP3 recombinant proteins
were expressed in E. coli.T h eG S T - 2 C
ATPase proteins were expressed
from pGEX-2C vector and purified by glutathione sepharosecolumn
(GE Healthcare) as described before [41]. The His-VP3 proteins
were purified by nickel column chromatography (QIAGEN).
GST pull-down assay
Briefly, 5 mg GST-2C
ATPase (or 2 mg GST as a control) were
incubated with glutathione sepharose beads at 4uC for 3 hr in
buffer containing 50 mM Tris-HCl pH7.5, 140 mM NaCl, 0.1%
TritonX-100 with protease inhibitor cocktail tablets (Roche). The
protein bound GSH beads were washed with PBS 3 times and
then 5 mg His-VP3 was added. After 1 hr incubation at 4 degree
Celsium, the glutathione beads were washed 3 times and were
boiled in 1x SDS sample buffer for 5 min. The samples were
analyzed by SDS-polyacrylamide gel (12.5% acrylamide) electro-
phoresis and followed by western blot analysis using antibodies
against PV VP3 (polyclonal, kindly contributed by Dr. Delpeyr-
oux, Pasteur Institute, France).
Co-immunoprecipitation assay using 2C
ATPase and VP3
proteins translated in an in vitro cell-free translation
system
Plasmids used for in vitro translation of CAV20 structural protein
VP3 (wt), VP3 (E180G) and CAV20 non-structural protein
2C
ATPase (wt), PV non-structural proteins 2C
ATPase (wt) and
2C
ATPase (N252S) were generated with A2 plasmid [55] and PCR
fragments encoding wt and mutant proteins of VP3 and 2C
ATPase
according to methods described previously [55]. 2 mg of each VP3
and 2C RNA transcripts generated in vitro by T7 RNA polymerase
were co-translated in HeLa extract and labeled by
35S-labeled
methionine. Using anti-PV 2C polyclonal antibody, Co-IP assay
was performed with co-translated
35S labeled 2C
ATPase and VP3
proteins following standard protocols using protein A/G plus-
agarose (Santa Cruz Biotechnology) and [56]. The radioactive
signals from input proteins and Co-IP reaction products were
quantified by a PhosphorImager (Molecular Dynamics, Storm
860) by measuring the amount of
35S incorporated into product.
Interactions between 2C
ATPase and VP3 were represented by
percentages of the levels observed in the Co-IP reaction with CAV
2C
ATPase and CAV VP3 after normalizing the amount of input
2C
ATPase and VP3. Numbers given for the extents of interactions
represented the average of three independent experiments.
Results
Rationale for generating PV and CAV chimeras to study
enterovirus encapsidation
The lack of evidence for an RNA packaging signal in
enterovirus proliferation has prompted us to study the specificity
Interaction of 2C
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interactions needed for this process. Previous studies have shown
that chimeric constructs of the PV polyprotein with exchanges of
varying coding regions of closely related picornaviruses can be
utilized to analyze determinants of viral macromolecular interac-
tions and replication [57,58,59,60,61,62]. PV and C-CAVs share a
high degree of amino acid identity in their nonstructural proteins
but are not closely related in their capsid sequences probably
because they evolved to use different cellular receptors [48]. In a
chimera with the capsid of one C-HEV and the nonstructural
proteins of another C-HEV, this difference may produce specific
morphogenesis phenotypes due to incompatibility or poor inter-
action between capsid and nonstructural proteins. In our previous
work, we have already observed that the replacement of the PV
type 1 Mahoney (PVM) capsid with that of its closest relative,
CAV20, resulted in a quasi-infectious virus, C20PP (Figure 2A)
[48]. In C20PP, the first letter refers to the origin of the P1 region,
the 2nd and 3rd letters refer to the origins of the P2 and P3
regions, respectively. The quasi-infectious phenotype means that a
step in the life cycle of C20PP is so severely debilitated that only
escape variants can be recovered from transfections with RNA
transcripts [48]. The molecular basis of the defective phenotype of
C20PP was not elucidated but could be proteolytic processing of
the capsid precursor, genome replication or encapsidation. The
observed quasi-infectious phenotype of C20PP made it possible to
subject this chimera to a genetic analysis that may reveal a defect
in encapsidation.
C20PP is defective in encapsidation
We first provided evidence that the quasi-infectious phenotype
of C20PP was not due to abnormal translation or protein
processing resulting from poor compatibility between the heter-
Figure 2. Chimeric virus C20PP containing the capsid-coding region of CAV20 is defective in encapsidation. (A) Growth phenotypes of
the parental and of chimeric viruses. The genomic structures of the parental and of chimeric viruses used are illustrated on the left. PVM sequences
are shown with open boxes, CAV sequences are shown by black boxes. Nomenclature used for the chimeric viruses: the first letter refers to the origin
of the P1 region, the 2nd and 3rd letters refer to the origins of the P2 and P3 regions, respectively. RNA transcripts were transfected into HeLa H1 cells
and the viruses obtained at CPE, if any, were titered by a plaque assay (Materials and Methods). (B)C 20PP is normal in translation and polyprotein
processing. RNA transcripts (500 ng) derived from wt PVM, wt CAV20 and C20PP were translated in vitro in HeLa cell extracts at 34 degree Celsius u
overnight, as described in Material and Methods. The reaction mixtures were analyzed by SDS/PAGE with 12% acrylamide and the viral proteins were
visualized by autoradiography. The positions of the precursor and mature proteins after processing are indicated. (C) The genomic structures of the
parental and of chimeric luciferase reporter viruses used are illustrated. The R-Luc gene is shown in dotted box. (D) Comparison of RNA replication
and encapsidation of the parental and of chimeric reporter viruses. To determine the level of RNA replication (black bar), RNA transcripts were
transfected into HeLa H1 cells both in the absence and presence of 2 mM GnHCl. To determine encapsidation (grey bar), the transfected cell lysates
were passaged into fresh HeLa H1 cells in the absence and presence of GnHCl. The luciferase activity in the absence (2GnHCl) and presence of 2 mM
GnHCl (+GnHCl) was measured and the ratio of luciferase activity (–GnHCl/+GnHCl) was calculated to quantify the extent of replication (Materials and
Methods). The luciferase data are the averages of at least three independent experiments.
doi:10.1371/journal.ppat.1001066.g002
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pro polypeptide in C20PP. Translation
of RNA transcripts of wt and chimeric constructs in a HeLa cell-
free extract [11] showed normal translation and protein processing
patterns (Figure 2B).
The search for the block of C20PP proliferation led us to develop
a novel reporter virus in which the PV open reading frame (ORF)
of the Renilla Luciferase (R-Luc) protein was fused to the N-
terminus of the viral polyprotein. In the course of the infection the
R-Luc is cleaved off from the viral polyprotein at an engineered
3CD
pro proteinase cleavage site. Due to the small size of the
inserted R-Luc gene this virus was stable for 1 passage after
transfection and, thus, suitable for our experiments. This construct
is similar to a previously described recombinant coxsackie B3 virus
that stably expressed eGFP in tissue culture [63]. The advantage of
using our reporter virus over conventional reporter replicons, in
which the P1-coding sequence is replaced by the luciferase gene, is
that it can distinguish between a defect in replication and
encapsidation. A reporter viral genome (with the R-Luc sequence)
that is unable to encapsidate itself will exhibit normal RNA
replication levels as evidenced by a wt-like Renilla luciferase signal
after RNA transfection. However, it would not generate infectious
progeny and, consequently, passage to fresh cells will fail, leading
to the loss of the luciferase signal.
We have made such reporter viruses from both the parental wt
CAV20 and the chimeric C20PP (Figure 2C). RNA transcripts
were transfected into HeLa H1 cells both in the absence and
presence of 2 mM GnHCl, a potent inhibitor of PV [18] and
CAV20 RNA replication [18,48]. Luciferase activity was deter-
mined at 16-hr post transfection either in the presence of GnHCl
(+GnHCl) throughout the incubation period that allows us to
measure the translation of the transfecting RNA, or in the absence
of GnHCl (2GnHCl) when the luciferase signal is increased
because of RNA synthesis. The ratio of the luciferase signals –
GnHCl/+GnHCl indicates the extent of genome replication. As
shown in Figure 2D there was a 100 fold increase of the luciferase
signal at 2GnHCl compared to +GnHCl with both wt R-Luc-
CAV20 and R-Luc-C20PP viruses, an observation indicating
robust RNA synthesis under these conditions. Lysates of
transfected cells were then inoculated to fresh HeLa H1 cells as
1
st passage either in the presence or absence of GnHCl. Eight
hours post infection the luciferase activity was measured
(Figure 2D). The high level of luciferase activity obtained after
the first passage of the R-Luc-CAV20 virus indicated the
formation of virions that had encapsidated the wt genome in the
course of transfection. In contrast, no luciferase signal could be
detected after passage of the lysate harboring the R-Luc-C20PP
chimera (Figure 2D). We conclude that the genome of the C20PP
chimera, although competent in RNA replication, cannot form
infectious progeny, e.g. it is defective in genome encapsidation.
The reason for the defect in encapsidation, however, remains
elusive.
The encapsidation defect of chimera C20PP is rescued
either by a mutation in capsid protein VP3 or by a
mutation in the nonstructural protein 2C
ATPase
As mentioned above, the C20PP chimera is quasi-infectious.
Variants that escaped the block in encapsidation were found only
after three blind passages following transfection. This indicated the
emergence of mutation(s). To identify the rescuing mutation(s), we
plaque purified two viruses that had emerged after three passages
from two independent transfections with C20PP transcripts. RT-
PCR and sequence analyses of the viral genomes revealed two
independent single mutations that mapped to the coding region of
either VP3 (E180G) or 2C
ATPase (N252S). By separately
engineering these two mutations back into the cDNA of C20PP
we obtained two viable viruses C20PP-VP3
E180G and C20PP-
2C
N252S (Figure 3A). Their titers after transfection were as low as
those observed with isolates after three passage of C20PP
(Figure 2A) and 1000 fold lower than that observed with wt
CAV20. Moreover, C20PP-VP3
E180G and C20PP-2C
N252S ex-
pressed a small plaque phenotype compared to that of wt CAV20
(Figures 2A and 3A).
The double mutation (VP3
E180G&2C
N252S) fully rescues
C20PP to a wt encapsidation phenotype
The phenotypes of C20PP-VP3
E180G and C20PP-2C
N252S did
not change after further passages, e.g. all attempts to isolate
variants with improved proliferation phenotypes failed (data not
shown). This prompted us to engineer both the VP3
E180G and
2C
N252S mutations into C20PP (C20PP-DM). Variant C20PP-DM
expressed phenotypes (virus titer and plaque size) almost the same
as that of wt CAV20 (compare Figures 2A and 3A). Currently, we
cannot explain why in our experiments the C20PP-DM-like variant
did not evolve during passaging of C20PP.
To confirm the rescue of the encapsidation defect of C20PP by
the mutations in VP3 and 2C
ATPase, we constructed reporter
viruses R-Luc-C20PP-VP3
E180G, R-Luc-C20PP-2C
N252S and R-
Luc-C20PP-DM (Figure 3B). All three produced strong luciferase
signals after transfection of their genomic RNAs into HeLa H1
cells, as expected (Figure 3C). After a passage into fresh HeLa H1
cells, the luciferase activity was highly impaired with C20PP but
was found to be partially rescued if the virions carried the single
2C
N252S or VP3
E180G mutation or fully rescued by the double
mutation (Figure 3C). Thus, although a single mutation can
partially rescue the proliferation phenotype of C20PP, the double
mutation 2C
N252S/VP3
E180G in the genome of the chimera is
capable of producing a proliferation phenotype similar to that of
wt CAV20. This observation, confirms the previous genetic data
by Vance et al. [32] that the coding region of 2C
ATPase is linked to
encapsidation. More importantly, the cooperative activity of VP3
with 2C
ATPase suggests that capsid protein VP3 functions through
a direct interaction with 2C
ATPase in encapsidation. As indicated
before, the coding sequence of 2C
ATPase, however, can be
eliminated as carrying an encapsidation signal. The cre, the only
known essential RNA structure in coding sequence of 2C
ATPase, are
highly homologous in sequence between PV and CAV20.
Moreover, scrambling of the P2 RNA sequence has no influence
on PV proliferation if the essential cre is transplanted to the 59NTR
(Song, Mueller, Ward, Skiena, Futcher, Paul, and Wimmer,
manuscript in preparation). It is, thus, likely that VP3 and 2C
ATPase
or their precursors cooperate by protein-protein interaction, a novel
mechanism for specific genome encapsidation of enteroviruses.
A CAV20-like 2C
ATPase rescues the encapsidation defect
of C20PP
It should be noted that the mutation in 2C
ATPase, which rescues
in part the encapsidation of C20PP-2C
N252S, is an N/S change in
PV 2C
ATPase at position 252 (Figure 4A). Amino acid sequence
alignment demonstrated that CAV20 has a Gly at this position
(Figure 4A), an observation indicating that a CAV-20 like,
uncharged residue might be favorable at this position. Thus, since
C20PP-2C
N252S expressed a severe encapsidation phenotype, it
was of interest to determine whether a C20PP-2C
N252G mutant
would yield a chimera equal or superior in encapsidation to
C20PP-2C
N252S. Similar to C20PP-2C
N252S, the N252G mutation
in the PV 2C
ATPase only partially rescued the encapsidation
phenotype of C20PP (Figure 4B). The observed N/S mutation in a
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reasoning that the CAV20-like N/G change in codon N252
would have required two nucleotide changes (AAT/GGT) while
the N/S mutation entails only a single nucleotide change (AAT/
AGT). Overall, the CAV20 like single amino acid change at 252 of
PV 2C
ATPase was favorable but not sufficient to fully rescue the
VP3-related function of the PV 2C
ATPase protein in encapsidation.
Based on this observation, we reasoned that the replacement of
the entire 2C
ATPase coding region in C20PP with its CAV20
counterpart should yield a chimera whose protein/protein
interaction required for encapsidation would be sufficient and,
thus, yield a virus with proliferation phenotypes similar to that of
wt CAV20. Therefore, we generated a chimera designated as
C20P(C20
2C)P that showed CPE after transfection with a virus titer
comparable to that of wt CAV20 (compare Figures 2A and 4B).
These results provide further support for the hypothesis that the
2C
ATPase protein is a partner required for encapsidation. It should
be noted that the chimera C20P(C20
2C)P had a growth phenotype
more similar to that of the wt CAV20 virus than the chimera
C20PP-2C
N252S (compare Figures 2A and 4B), an observation
indicating that sequences besides residue 252 in 2C
ATPase are also
important for function during viral encapsidation.
The encapsidation of other C-CAV chimeras requires
capsid protein(s) and 2C
ATPase of the same origin
The observationthatCAV20 VP3needsitsown2C
ATPasetofully
rescue the defect in encapsidation suggests that the cooperation or
interaction between 2C
ATPase and capsid might be specific and
generally true for C-HEVs. To test this hypothesis we extended our
analyses to CAV18 and CAV21, two viruses that are phylogenet-
ically related to CAV20 and PV [48]. Chimeras C20C21C21 and
C18C20C20 (Figure 5A) displayed non-viable phenotypes as judged
by the lack of virus in plaque assays even after 8 blind passages on
fresh HeLa H1 monolayers (Figure 5A). In order to test whether the
lethal phenotypes of the two chimeric viruses were due to the same
encapsidation defect as that of C20PP, we constructed reporter
Figure 3. Rescue of the C20PP virus by mutations in 2C
ATPase or/and in VP3. (A) Growth phenotypes of the C20PP chimera and of its
derivatives. The genomic structures of the C20PP virus and of its derivatives are illustrated on the left. For the nomenclature of the chimera see the
legend to Figure 2A. CAV20 sequences are shown with black boxes, PVM sequences with open boxes. The amino acid changes in 2C
ATPase and in VP3
are shown in superscript. C20PP-DM represents the double mutant. RNA transcripts were transfected into HeLa H1 cells and the viruses present after
complete CPE were titered by a plaque assay (Materials and Methods). (B) The genomic structures of the C20PP reporter chimeras, carrying the R-Luc
gene fused N-terminal to P1, and of its derivatives. (C) Comparison of RNA replication and encapsidation of the C20PP virus and of its derivative
reporter viruses. To determine the level of RNA replication (black bar), RNA transcripts were transfected into HeLa H1 cells both in the absence and
presence of 2 mM GnHCl. To determine encapsidation (grey bar), the transfected cell lysates were passaged into fresh HeLa H1 cells in the absence
and presence of GnHCl. Luciferase activity in the absence (2GnHCl) and presence of 2 mM GnHCl (+GnHCl) was measured and the ratio of luciferase
activity (–GnHCl/+GnHCl) was calculated to quantify the extent of replication (Materials and Methods). The luciferase data are the averages of at least
three independent experiments.
doi:10.1371/journal.ppat.1001066.g003
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(Figure 5B) just as that of CAV20 (Figure 2C). After transfection of
RNA transcripts into HeLa H1 cells, R-Luc activity at 16-hr post
transfection showed that the parental and chimeric viruses
replicated their genomes with nearly wt efficiency (Figure 5C).
However, after the first passage on fresh HeLa H1 cells only wt
CAV20 and wt CAV18 reporter viruses yielded normal luciferase
signals (Figure 5C). The chimeric genomes R-Luc-C20C21C21 and
R-Luc-C18C20C20 could not produce an infection, a result
demonstrating an encapsidation defect.
To test whether the lethal proliferation phenotypes of the two
chimeras (C20C21C21 and C18C20C20) are related to an incom-
patibility between the capsid and the 2C
ATPase proteins derived
from different parental viruses, we constructed new chimeras
[C20C21(C20
2C)C21,C 18C20(C18
2C)C20] in which the capsid and
2C
ATPase proteins were derived from the same origin (Figure 6A).
The resulting chimeras all showed CPE after transfection
(Figure 6B) and the virus titers were comparable to that of the
parental viruses (data not shown). The finding that the lethal
growth phenotypes of the chimeras were fully rescued when the
capsid and 2C
ATPase were derived from the same origin serves as
further support of our hypothesis that 2C
ATPase and capsid
proteins communicate with each other during the process of
encapsidation. So far, we have not been able to determine, by
continued passage, the necessary amino acid changes in the
2C
ATPase protein of CAV20 and CAV21 to allow encapsidation of
the C20C21C21 and C18C20C20 chimeras. This observation might
be explained by the fact that there are many amino acid
differences either between CAV20 and CAV21 or between
CAV20 and CAV18 flanking residue 252 of the 2C
ATPase protein
(Figure 6C). This may make it difficult for the two chimeras
(C20C21C21 and C18C20C20) to generate escape mutants simply by
natural selection during passages.
A direct interaction between proteins 2C
ATPase and VP3 is
revealed by biochemical assays
The genetic evidence described above strongly suggested a
direct interaction between the capsid proteins and 2C
ATPase, which
is required for encapsidation. To confirm this interaction, we
carried out a GST-pull down assay with purified PV proteins
GST-2C
ATPase and His-VP3 (Figure 7A, lane 2). The same assay
was performed with purified GST protein as a control (Figure 7A,
lane 1). Our results clearly showed that PV GST-2C
ATPase
interacts directly with the PV His-tagged VP3 protein. To provide
further proof that direct interaction between VP3 and 2C
ATPas is
required for the encapsidation process, co-immunoprecipitation
(Co-IP) assays were performed with VP3 and 2C
ATPase proteins in
three different combinations: CAV20 VP3 & CAV20 2C
ATPase,
CAV20 VP3 & PV 2C
ATPase, CAV20 VP3 (E180G) & PV
2C
ATPase (N252S), which correspond to those observed in wt
CAV20, nonviable chimera C20PP, and rescued C20PP-DM,
respectively. In vitro transcribed RNA transcripts of 2C and VP3
coding sequences in different combinations were co-translated in
HeLa cell extracts (Figure 7B, lanes 4–6) [11,55]. Using PV 2C
polyclonal antibody, which recognizes PV 2C
ATPase and CAV20
2C
ATPase with the same efficiency (data not shown) [56], CAV20
VP3 was co-immunoprecipitated readily by CAV20 2C
ATPase
(100%, Figure 7B, lane 1) but only weakly by PV 2C
ATPase (32%,
Figure 7B, lane 2). The extent of interaction between 2C
ATPase and
VP3 was quantified using a PhosphorImager and is expressed as
percentage of the level observed in the CAV20 2C
ATPase and
CAV20 VP3 Co-IP reaction. These results indicated a strong,
direct interaction between 2C
ATPase and VP3 of the same origin
(CAV20) but not between PV 2C
ATPase and CAV20 VP3, a
combination that yielded the nonviable C20PP chimera. In
contrast, the interaction between PV 2C
ATPase (N252S) and
CAV20 VP3 (E180G) proteins was restored (78%, Figure 7B, lane
Figure 4. Rescue of the C20PP virus by a CAV20-like amino acid or CAV20 2C
ATPase. (A) Comparison of the amino acid sequences of
2C
ATPase flanking residue 252 of PVM, CAV20 and C20PP-2C
N252S.( B) The genomic structures of the C20PP derivatives. Note that the 2C
N252G change is
different from what was observed in the encapsidation adapted virus (2C
N252S). N252S mutation in C20PP-2C
N252S is shown by grey diamond whereas
the N252G mutation is a black diamond. For nomenclatures see the legend to Figure 2A. The PVM sequences are shown with open boxes and the
CAV sequences by black boxes. RNA transcripts were transfected into HeLa H1 cells and at the time of CPE the virus titers were determined by a
plaque assay (Materials and Methods).
doi:10.1371/journal.ppat.1001066.g004
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ATPase
and CAV20 VP3, respectively, This observation, which correlates
with the rescue of the nonviable phenotype of C20PP by the two
mutations, strongly support the notion that sufficient protein-
protein interaction between 2C
ATPase and VP3 is essential for the
encapsidation process. The same Co-IP assays were also
performed with a-actin antibody and empty resin as controls to
ensure that the interactions were not due to non-specific binding of
the proteins to the antibody or to the resin (data not shown). It
should be noted that there was an extra protein band shown below
the band of 2C
ATPase in each of the input lanes (Figure 7B, lane 4–
6, indicated by asterisk), which was possibly generated from the
internal initiation or premature termination of the translation of
RNA transcripts of 2C coding sequences. Apparently these
incomplete translation products could not be recognized by the
2C antibody since protein bands disappeared after Co-IP
(Figure 7B, lane 1–3). These results confirm the specificity of the
Co-IP assay in which the detection of the VP3 protein was due to
its co-immunoprecipatation with the 2C
ATPase protein, recognized
by anti-2C
ATPase antibody.
The data support our hypothesis that 2C
ATPase is required for
viral encapsidation through a direct interaction with capsid protein
VP3 and also confirm that 2C
ATPase interacts with VP3 through
protein–protein rather than RNA-protein interaction. Given that
2C
ATPase and capsid proteins are colocalized on the surface of
membranous vesicles in the RNA replication complex [46,47], it is
likely that 2C
ATPase interacts with VP3 either in the form of the
mature protein or in the context of one of the VP3-containing
capsid precursors (5S, 14S, 75S and 150S).
Discussion
The mechanism of picornavirus genome encapsidation has been
a conundrum for many years. In previous studies on poliovirus
morphogenesis, mostly trans encapsidation experiments were
performed to determine the specificity of PV morphogenesis. In
Figure 5. Chimeras of C-CAVs, C20C21C21 and C18C20C20, are defective in encapsidation. (A) Growth phenotypes of parental and of
chimeric viruses. The genomic structures of the parental and chimeric viruses are shown on the left. CAV20 sequences are shown by black boxes,
CAV21 by gray boxes and CAV18 by hatched boxes. The nomenclature for the chimeric viruses is given in the legend to Figure 2. RNA transcripts
were transfected into HeLa H1 cells and the viruses obtained at CPE, if any, were titered by plaque assay (Materials and Methods). (B) The genomic
structures of the parental and chimeric luciferase reporter viruses. (C) Comparison of RNA replication and encapsidation of the parental C-CAVs and
of chimeric C-CAVs reporter viruses. To determine the level of RNA replication (black bar), RNA transcripts were transfected into HeLa H1 cells both in
the absence and presence of 2 mM GnHCl. To determine encapsidation (grey bar), the transfected cell lysates were passaged into fresh HeLa H1 cells
in the absence and presence of GnHCl. The luciferase activity in the absence (2GnHCl) and presence of 2 mM GnHCl (+GnHCl) was measured and the
luciferase activity ratio (–GnHCl/+GnHCl) was calculated to quantify the extent of replication (Materials and Methods). The luciferase data are averages
of at least three independent experiments.
doi:10.1371/journal.ppat.1001066.g005
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from a different molecular entity to the parental genome either by
coinfecting picornaviruses [14], by the vaccinia system [22,23] or
by expression from co-transfected cDNAs [64]. However,
differences in the experimental design also affect the outcome of
the experiments. Jia et al., [64] have reported trans-encapsidation
of PV replicons into capsids of coxsackie B3, human rhinovirus 14,
and coxsackie B24 viruses. These data, however, are in contrast to
those of Porter et al., [23] and Barclay et al., [14], who failed to
trans encapsidate the reporter PV replicon by super-infecting with
CAV21.
In the current study, we have used a novel system to study
encapsidation of closely related enteroviruses, the C-cluster
enteroviruses (C-HEVs). They consist of two classes of virus
serotypes: PV and C-CAVs. We have made use of differences
between these viruses to investigate the effect of capsid exchanges
on C-HEV morphogenesis. By studying a variety of C-HEV
chimeric viruses in which the capsid P1 precursors were
exchanged, we now present direct evidence for the involvement
of 2C
ATPase in enterovirus morphogenesis via direct interaction
with capsid protein VP3. Different from trans encapsidation assays,
in which the capsid proteins are offered from a different molecular
entity to the parental genome, our experiments were designed to
measure cis encapsidation of genomes, in which the capsid is
provided (generated) by the chimeric genome itself. It appears that
in these chimeras the non-structural proteins are more discrim-
inatory to capsid proteins because they are required to
proteolytically process the heterologous capsid precursor. In
addition, the quality and quantity of the heterologous capsid
proteins produced might not be ideal for the chimeric genome. As
we have shown here, favorable conditions for encapsidation are
rarely met in the chimera, even if the viruses are as closely related
as PV and CAV20.
In a previous study on genetic recombination between PV and
C-CAVs, we observed that capsid chimera C20PP initially could
not grow [48], an observation indicating that it harbors defect(s)
debilitating the viral replication life cycle. Translation in HeLa cell
extracts showed, however, that both translation and proteolytic
processing of the CAV20 capsid precursor in C20PP was
unimpaired. This is not surprising since the 3CD
pro proteins of
poliovirus and CAV20 are closely related in amino acid sequence
[48] and because the 3CD
pro cleavage sites within the P1
precursor of PVM and CAV20/21 are well conserved (Supple-
mentary Table 1 in Text S1). These two facts reduce the likelihood
of a processing defect of the foreign capsid precursor prior to
packaging. In contrast, a chimera consisting of the PV capsid and
Figure 6. Rescue of lethal C-CAV chimeras by 2C
ATPase of the same origin as P1. (A) Genomic structures of the chimeric viruses containing
both the P1 and 2C
ATPase regions from the same origin. For the genomic structures of the chimeric viruses with only P1 exchanges see Figure 4A.
CAV20 sequences are shown with a black box, CAV21 sequences with a gray box and CAV18 sequences with a hatched box. For the nomenclature of
the chimeric viruses see the legend to Figure 2. (B) Comparison of growth phenotypes of the chimeric viruses with just P1 or with P1+2C
ATPase
exchanges. RNA transcripts were transfected into HeLa H1 cells and the plaque phenotype of the virus, if any, was tested at the time of CPE (Materials
and Methods). (C) Comparison of the amino acid sequences flanking residue 252 of 2C
ATPase among CAV20, CAV18 and CAV21.
doi:10.1371/journal.ppat.1001066.g006
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dead but it also revealed a processing defect of the PV capsid
precursor [65]. CBV3 is an enterovirus belonging to the B-cluster,
and its genetic kinship with PV is much more distant than that
between PV and CAV20. Thus, CBV3 3CD
pro proteinase was
apparently unable to properly cleave the PV capsid precursor.
Similar results were obtained with a chimera of PV in which the
3C-coding region was derived from HRV14. The foreign
proteinase was not capable of recognizing the PV-specific
processing sites within the capsid precursor [57].
The robust RNA replication phenotype of C20PP demonstrated
here with the use of a new reporter virus construct suggested to us
that this chimera might be quasi-infectious with respect to
encapsidation. This was proven to be correct since viable viruses
were found upon blind passages of C20PP but they harbored
mutations. The virus isolates from two independent transfections
contained a mutation either in 2C
ATPase (N252S) or in VP3
(E180G). Either of these single mutations was able to partially
rescue the defective encapsidation and growth phenotype of
C20PP. Introducing both mutations together into the C20PP
genome fully rescued packaging and resulted in normal production
of progeny virus. It is noteworthy that we never found both
mutations in a single isolate even after eight passages. Perhaps the
mutations conferred to the variants too little of an advantage to be
selected under the conditions of the experiments. As discussed
earlier, an involvement of essential RNA sequences in the
2C
ATPase and VP3 coding sequences during the process of
encapsidation can be excluded. A direct interaction between the
2C
ATPase and VP3 proteins, suggested by the genetic experiments,
was confirmed by biochemical assays using either purified or in
vitro translated PV and CAV20 proteins. It should be noted that
2C
ATPase also functions in the viral life cycle in the form of its
precursor 2BC
ATPase. A requirement of an interaction between
2BC
ATPase and VP3 for packaging is, however, unlikely since 2B is
less homologous between PV and CAV20 in sequence than
2C
ATPase and the exchange of the mature 2C
ATPase protein alone
is sufficient for full rescue. We are currently investigating whether
the interaction between 2C
ATPase and VP3 involves the mature
VP3 polypeptide or one of the capsid intermediates during viral
assembly and/or maturation.
The encapsidation defect of C20PP could also be rescued by
replacing the entire 2C
ATPase coding sequence of PV with that of
CAV20. Additional experiments indicated that the lethal growth
phenotypes of other CAV/CAV capsid chimeras could also be
reversed by replacing their 2C
ATPase coding sequence with that of
the capsid donor virus. It is noteworthy that these observations are
not contradictory to the scenario of another chimera previously
described. PC20C20, which, in contrast to C20PP, possesses a
Figure 7. Direct interaction between VP3 and 2C
ATPase demonstrated by biochemical assays. (A) GST pull down assay. PV GST-2C
ATPase,
PV VP3-His and GST were purified as described in Materials and Methods. Lane 1: GST was used to pull down PV VP3-His; Lane 2: PV GST-2C
ATPase was
used to pull down PV VP3-His. (B) Co-immunoprecipitation (Co-IP) assays. RNA transcripts containing 2C and VP3 coding sequences of PV or CAV20,
were co-translated in HeLa cell extracts in the presence of
35S-methionine. Lane 4: input CAV20 2C
ATPase & CAV20 VP3; Lane 5: input PV 2C
ATPase &
CAV20 VP3; Lane 6: input PV 2C
ATPase (N252S) & CAV20 VP3 (E180G). The positions of 2C
ATPase and VP3 are indicated. The position of incomplete
translation products of RNA transcripts of 2C coding sequence is indicated by asterisk. Using polyclonal antibody against PV 2C
ATPase, Co-IP assays
were done as described in Materials & Methods. The co-immunoprecipitated protein products from co-translation reactions shown in lanes 4, 5 and 6
were loaded in Lanes 1, 2, 3, respectively, analyzed by SDS-PAGE, and detected by autoradiography. The extent of interactions was quantified and
calculated as percentages of the levels observed in the CAV 2C
ATPase and CAV VP3 Co-IP reaction (shown below).
doi:10.1371/journal.ppat.1001066.g007
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protein sequences, grows as well as wt PV [48]. We have
previously proposed that the evolutionary direction is from C-
CAV to PV within C-HEVs resulting in a receptor switch from
ICAM-1 to CD155 during the speciation [48]. If so, the newly
emerged PV capsid may still be compatible with 2C
ATPase of the
C-CAV ancestors and achieve sufficient interaction required for
encapsidation.
Our data also clarify some unanswered questions about previous
trans encapsidation experiments using poliovirus replicons con-
taining a reporter gene in the capsid-coding region [14,23]. Those
studies showed that CAV21 was not able to encapsidate a PV
replicon even though co-infection of cells with CAV21 resulted in
high levels of replication of both CAV21 and the PV replicon. The
most likely reason for those results is that the CAV21 capsid,
similar to CAV20 capsid, fails to properly interact with PV
2C
ATPase. From their studies with hydantoin, Vance et al., have
suggested that 2C
ATPase might have a role in encapsidation by an
association of the progeny RNA with the capsid [32]. In other
experiments with the same drug, however, Oh et al., [66] have
recently proposed that hydantoin inhibits the release of the
progeny RNA from the replication complex prior to encapsida-
tion. Whether the interaction between 2C
ATPase and VP3, as we
have observed in our studies, is required during or just before the
union of the RNA with capsid proteins remains to be determined.
An intriguing phenomenon of poliovirus encapsidation is that
only newly replicated RNA molecules are incorporated into
virions [11,12], an observation reported also for some other RNA
viruses such as flock house virus [67,68,69], and brome mosaic
virus [70]. Coupling encapsidation specifically with replication
offers an efficient mechanism of discriminating against cellular
RNAs or viral mRNA. Since genome replication is coupled with
translation [71,72] the link to encapsidation ‘‘can impose a form of
late proofreading’’ for the progeny virus [12]. In Figure 8, we
present a model of morphogenesis that is based, admittedly, on
much speculation. We currently propose that in the context of the
membrane-associated replication complex 2C
ATPase will directly
interact with a 14S pentamer via VP3. The pentamer will then
bind the newly emerging, VPg-linked genomic RNA [9] while the
assembly of the virion proceeds in close contact with the
Figure 8. Model for C-HEVs morphogenesis involving the interaction between 2C
ATPase and capsid protein VP3. Following its release
from the polyprotein by 2A
pro, P1 is first properly folded by chaperone Hsp90 before it becomes a substrate for 3CD
pro[4,5]. Mature VP0, VP1 and VP3
assemble into a protomer, 5 of which subsequently form a pentamer. Some pentamers generate 75S empty capsids. Progeny viral RNA, released from
the replication complexes, is associated with pentamers [9] through their VP3 domains that interact with 2C
ATPase on the surface of membranous
replication complexes. 12 pentamers assemble to enclose the viral RNA forming a provirion. Maturation cleavage of VP0 to VP2 and VP4 yields an
infectious virion. The role of 3CD
pro at this step is not yet understood [30].
doi:10.1371/journal.ppat.1001066.g008
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for the specificity of enterovirus encapsidation: it is dependent on
protein/protein interactions at the site of the active replication
complex.
It is likely that our model will be applicable to most, if not all,
picornaviruses as well as to other families of plus strand RNA
viruses. For example, the requirement for an interaction between a
capsid protein and nonstructural proteins for encapsidation has
also been observed for members of the Flaviviridae. Murray et al.,
reported that several assembly-deficient core mutants of HCV
genotype 2a (Hepacivirus genus) could be rescued by compensatory
mutations in p7 or NS2 [73]. In addition, it was shown that HCV
core and NS5A colocalize on the surface of lipid droplets, a
process required for particle assembly [74]. Furthermore, recent
reports indicate the importance of nonstructural proteins in the
maturation of Kunjin virus and Yellow fever virus (Flavivirus genus)
[75,76] and of bovine diarrhea virus (Pestivirus genus) [77].
We have noted before that Aichi virus, a member of the
Kobuvirus genus in the Picornaviridae, requires a 59-terminal RNA
element for encapsidation [29]. This signal by itself, however, is
not sufficient to confer encapsidation specificity since it can be
replaced by a similar stem loop from hepatitis A virus, a member
of the genus Hepatovirus of Picornaviridae, and the resulting chimera
expresses a severe proliferation phenotype [27]. On the other hand
different genera of Picornaviridae may have evolved different
strategies of encapsidation. This is not entirely unlikely considering
the fundamentally different strategies that different genera of
Flaviviridae are using to control genome translation (cap-dependent
vs. IRES-dependent initiation of translation [78].
Our model does not explain, however, how VPg-linked minus-
stranded poliovirus RNA is discriminated against in encapsidation.
Previous studies have reported that several picornaviral 2C
ATPase
proteins bind specifically to the 39-end of minus strand RNA in vitro
[79,80]. However, the importance of this interaction, if any, for
encapsidation is unlikely. Normally, plus strands are produced in
great excess over minus strands [81], a phenomenon thought to
lead to the depletion of free minus strands by forming the
replicative form (RF) or replication intermediates (RI) [18]. If the
balance between the plus and the minus strands is disturbed, free
minus strands may emerge from the replication complex and they
may then be encapsidated. Indeed, encapsidation of both plus and
minus strand genomic RNAs was observed in non-cytopathogenic
CBV3 that were isolated from persistently infected murine hearts
and cardiac myocyte cultures [82]. It is possible that the non-
cytopathogenic CBV3 produces minus stranded RNA in excess
such that it will emerge from replication complexes where capsid
precursors are waiting to encapsidate them. Whether the ‘‘cap’’ of
a positively charged VPg on both plus or minus strands plays a role
in this process remains to be seen.
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